Abstract
AbstractThe most abundant natural collagens form heterotrimeric triple helices. Synthetic mimics of collagen heterotrimers have been found to fold slowly, even compared to the already slow rates of homotrimeric helices. These prolonged folding rates are not understood and have not been studied. This work compares three heterotrimeric collagen mimics’ stabilities, specificities and folding rates. One of these was designed through a computational-assisted approach, resulting in a well-controlled composition and register, in addition to providing increased amino acid diversity and excellent specificity. The crystal structure of this heterotrimer elucidates the composition, register and geometry of pairwise cation-π and axial and lateral salt bridges. Complementary experimental methods of circular dichroism and NMR suggest the folding paradigm is frustrated by unproductive, competing heterotrimer species and these species must completely unwind to the monomeric state before refolding into the thermodynamically favored assembly. This collagen heterotrimer, which displays the best reported thermal specificity, was also found to fold much faster (hours vs days) than comparable, well-designed systems. The heterotrimeric collagen folding rate was observed to be both concentration and temperature-independent, suggesting a complex, multi-step mechanism. These results suggest heterotrimer folding kinetics are dominated by frustration of the energy landscape caused by competing triple helices.
Publisher
Cold Spring Harbor Laboratory
Reference59 articles.
1. Collagen-like proteins of pathogenic streptococci
2. Collagen fragments modulate innate immunity. Experimental Biology and Medicine (Maywood;N.J,2007
3. Gordon, M. K. ; Hahn, R. A. Collagens. Cell Tissue Res. 2009, 339, 247.
4. Nature’s hierarchical materials
5. Abendstein, L. ; Dijkstra, D. J. ; Tjokrodirijo, R. T. ; van Veelen, P. A. ; Trouw, L. A. ; Hensbergen, P. J. ; Sharp, T. H. Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains. Nat. Comm. 2023, 14, 4027.